Jim O'Neill

By: Jim O'Neill on May 21st, 2026

Print/Save as PDF

Laboratory Business Insights- May 2026 (Jim's Edition)

Newsletter

 A Message from Jim:

40 Years of Experience in Billing, Collections, and Laboratory Information Systems

Welcome to Laboratory Business Insights, a complimentary newsletter focused on the operational, financial, and technology challenges facing today’s laboratory industry. After four decades working in laboratory billing, collections, revenue cycle management, and LIS implementation, I’ve seen our industry evolve from paper requisitions and manual posting to AI-driven analytics, automation, and advanced interoperability.

The laboratory business continues to face increasing pressure from payer audits, reimbursement cuts, staffing shortages, compliance oversight, and rapidly changing technology requirements. At the same time, laboratories that invest in strong operational controls, experienced revenue cycle management, and scalable LIS platforms are finding opportunities for growth and improved profitability.

Laboratories navigating reimbursement pressure and operational challenges in 2026 can also explore ADS’s Interactive Laboratory Survival Guide for additional insights and industry trends.


Key Industry Challenges in 2026

Reimbursement Pressure Continues

Payers continue tightening reimbursement policies with increased scrutiny on medical necessity, prior authorization requirements, diagnosis validation, and documentation support. Many laboratories are seeing:

  • Higher denial rates
  • Increased pre-payment audits
  • Delayed reimbursements
  • More aggressive recoupment activity


Successful laboratories are focusing on:

  • Strong front-end eligibility verification
  • Automated claim edits
  • Real-time denial management
  • Data-driven appeals processes

ADS recently released a complimentary 2027 Laboratory Scorecard designed to help laboratories evaluate operational vulnerabilities, reimbursement exposure, and revenue cycle performance.


The Growing Importance of LIS Integration

A modern Laboratory Information System is no longer simply a reporting platform. Today’s LIS must support:

  • Full billing integration
  • Electronic ordering
  • EMR interoperability
  • Compliance tracking
  • Real-time analytics
  • Automation workflows


Laboratories operating on outdated or disconnected systems often struggle with claim delays, missing documentation, manual errors, and lost revenue opportunities.

Over the years, I’ve worked with laboratories ranging from small physician-office labs to large reference laboratories. One consistent lesson remains true: operational efficiency begins with accurate data flow between the LIS and billing systems.

Denials Are No Longer “Back Office Problems”

Denial management has become one of the largest revenue risks in laboratory operations. Laboratories that simply “rebill and hope” are losing significant revenue every month.


The most successful organizations now treat denials as:

  • Operational intelligence
  • Payer behavior tracking
  • Compliance indicators
  • Workflow improvement opportunities


Experienced billing teams understand that resolving denials requires:

  • Deep payer knowledge
  • Accurate coding review
  • Documentation analysis
  • Persistent follow-up
  • Strong appeal strategies

For laboratories evaluating how payer behavior, denials, and reimbursement pressure are impacting overall financial performance, ADS also published The State of Lab Revenue report.


AI and Automation Are Changing Laboratory Operations

Artificial intelligence is beginning to reshape:

  • Revenue cycle analytics
  • Claims prioritization
  • Denial prediction
  • Workflow automation
  • Management reporting


However, technology alone is not the answer. AI is most effective when combined with experienced management teams who understand laboratory operations, payer behavior, and compliance requirements.

The laboratories achieving the best financial performance today are combining:

  • Experienced operational leadership
  • Integrated LIS technology
  • Advanced billing analytics
  • US-based revenue cycle expertise
  • Strong compliance oversight


Fraud Investigations Continue to Impact the Industry

Recent fraud investigations within the laboratory and genetic testing sectors continue to create increased regulatory scrutiny across the industry. Unfortunately, fraud hurts the laboratories that play by the rules.


Compliance, documentation integrity, and proper billing practices are more important than ever. Laboratories must maintain:

  • Accurate ordering documentation
  • Medical necessity validation
  • Proper test utilization controls
  • Internal audit procedures
  • Strong compliance programs


Looking Ahead

The laboratory industry remains one of the most important components of healthcare delivery. Despite reimbursement challenges and operational pressures, laboratories that focus on technology integration, compliance, strong revenue cycle management, and customer service will continue to succeed.


After 40 years in this business, one thing remains clear: laboratories that combine operational discipline with experienced leadership consistently outperform those relying on short-term fixes or outdated systems.

Thank you for reading Laboratory Business Insights, a complimentary newsletter dedicated to helping laboratories improve operations, maximize collections, strengthen compliance, and better understand the business side of laboratory medicine.

— Jim O'Neill

Contact Information
Email: jim.o@adsc.com
Phone: 609-517-6242

About Jim O'Neill

As the company’s Laboratory Services Business Development Manager, Jim has 30 years’ experience in LIS and financial systems including 20 years as the owner of CSS (Avalon LIS). With a Bachelor’s degree in information technology from Rowan University, Jim has worked / consulted with over 500 labs in the US and internationally in improving their LIS and financial solutions. Jim is genuinely people-oriented and civic-minded; he’s the former Mayor of Northfield NJ and is currently on the town’s council.